Skip to main navigation Skip to search Skip to main content

Assessment of hepatocyte growth factor in ovarian cancer mortality

Ellen L Goode, Georgia Chenevix-Trench, Lynn C Hartmann, Brooke L Fridley, Kimberly R Kalli, Robert A Vierkant, Melissa C Larson, Kristin L White, Gary L Keeney, Trynda N Oberg, Julie M Cunningham, Jonathan Beesley, Sharon E Johnatty, Xiaoqing Chen, Katelyn E Goodman, Sebastian M Armasu, David N Rider, Hugues Sicotte, Michele M Schmidt, Elaine A ElliottEstrid Høgdall, Susanne Krüger Kjær, Peter A Fasching, Arif B Ekici, Diether Lambrechts, Evelyn Despierre, Claus Høgdall, Lene Lundvall, Beth Y Karlan, Jenny Gross, Robert Brown, Jeremy Chien, David J Duggan, Ya-Yu Tsai, Catherine M Phelan, Linda E Kelemen, Prema P Peethambaram, Joellen M Schildkraut, Vijayalakshmi Shridhar, Rebecca Sutphen, Fergus J Couch, Thomas A Sellers, Ovarian Cancer Association Consortium

33 Citations (Scopus)

Abstract

Invasive ovarian cancer is a significant cause of gynecologic cancer mortality.
Original languageEnglish
JournalCancer Epidemiology, Biomarkers & Prevention
Volume20
Issue number8
Pages (from-to)1638-48
Number of pages11
ISSN1055-9965
DOIs
Publication statusPublished - 2011

Keywords

  • Female
  • Genotype
  • Hepatocyte Growth Factor
  • Humans
  • Immunohistochemistry
  • Ovarian Neoplasms
  • Polymorphism, Single Nucleotide
  • Signal Transduction
  • United States

Fingerprint

Dive into the research topics of 'Assessment of hepatocyte growth factor in ovarian cancer mortality'. Together they form a unique fingerprint.

Cite this